Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener klinische Wochenschrift
Erschienen in:

13.01.2020 | short report

Added value of transthoracic 2D echocardiographic en face view of the tricuspid valve

verfasst von: Matthias Schneider, MD, Thomas Binder, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2020

Einloggen, um Zugang zu erhalten

Auszug

Previously published data clearly demonstrated a graded association of the degree of tricuspid valve regurgitation (TR) with morbidity and mortality [1‐5]. With transcatheter tricuspid valve (TV) interventions on the rise, imaging of the TV has increasingly come into the focus of echocardiographers as not only the severity of regurgitation but an exact morphological valve assessment is essential before the procedure [6‐9]. Pacemaker lead position can identify those patients who might benefit from lead repositioning [10]. Leaflet length, possible presence of accessory leaflets, and determination of the width of the coaptation defect can influence if a patient is eligible for transcatheter repair [9]. …
Vorheriger Artikel Impella®: an updated meta-analysis of available data and future outlook on applications in cardiogenic shock
Nächster Artikel Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Prihadi EA, van der Bijl P, Gursoy E, Abou R, Mara Vollema E, Hahn RT, et al. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur Heart J. 2018;39(39):3574–81.CrossRef
2.
Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–42.CrossRef
3.
Lee JW, Song JM, Park JP, Kang DH, Song JK. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J. 2010;74(2):375–80.CrossRef
4.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.CrossRef
5.
Kelly BJ, Ho Luxford JM, Butler CG, Huang CC, Wilusz K, Ejiofor JI, et al. Severity of tricuspid regurgitation is associated with long-term mortality. J Thorac Cardiovasc Surg. 2018;155(3):1032–1038.e2.CrossRef
6.
Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique. Circulation. 2017;135(19):1802–14.CrossRef
7.
Bartko PE, Arfsten H, Frey MK, Heitzinger G, Pavo N, Cho A, et al. Natural history of functional tricuspid regurgitation: implications of quantitative doppler assessment. JACC Cardiovasc Imaging. 2019;12(3):389–97.CrossRef
8.
Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18(12):1342–3.CrossRef
9.
Hausleiter J, Braun D, Orban M, Latib A, Lurz P, Boekstegers P, et al. Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. EuroIntervention. 2018;14(6):645–53.CrossRef
10.
Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7(4):337–47.CrossRef
11.
Hahn RT, Nabauer M, Zuber M, Nazif TM, Hausleiter J, Taramasso M, et al. Intraprocedural imaging of transcatheter tricuspid valve interventions. JACC Cardiovasc Imaging. 2019;12(3):532–53.CrossRef
12.
Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American society of echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64.CrossRef
13.
Schneider M, Pistritto AM, Gerges C, Gerges M, Binder C, Lang I, et al. Multi-view approach for the diagnosis of pulmonary hypertension using transthoracic echocardiography. Int J Cardiovasc Imaging. 2018;34(5):695–700.PubMed
14.
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–713. quiz 86–8.CrossRef
15.
Muraru D, Badano LP, Sarais C, Soldà E, Iliceto S. Evaluation of tricuspid valve morphology and function by transthoracic three-dimensional echocardiography. Curr Cardiol Rep. 2011;13(3):242–9.CrossRef
16.
Muraru D, Hahn RT, Soliman OI, Faletra FF, Basso C, Badano LP. 3‑dimensional echocardiography in imaging the tricuspid valve. JACC Cardiovasc Imaging. 2019;12(3):500–15.CrossRef
17.
Oh J, Seward J, Tajik A. Subcostal position. The echo manual. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 14–8.
18.
Stankovic I, Daraban AM, Jasaityte R, Neskovic AN, Claus P, Voigt JU. Incremental value of the en face view of the tricuspid valve by two-dimensional and three-dimensional echocardiography for accurate identification of tricuspid valve leaflets. J Am Soc Echocardiogr. 2014;27(4):376–84.CrossRef
Metadaten
Titel
Added value of transthoracic 2D echocardiographic en face view of the tricuspid valve
verfasst von
Matthias Schneider, MD
Thomas Binder, MD
Publikationsdatum
13.01.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-019-01601-z

Weitere Artikel der Ausgabe 3-4/2020

Prospective associations of cardiovascular disease with physical performance and disability

  • original article

Gender-specific differences in valvular heart disease

  • Open Access
  • review article

Interventional treatment of tricuspid regurgitation

  • editorial

Impella®: an updated meta-analysis of available data and future outlook on applications in cardiogenic shock

  • short report

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk

  • Open Access
  • consensus report

What is new in the 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy?

  • Open Access
  • review article